| Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B P Fisicaro, V Barili, B Montanini, G Acerbi, M Ferracin, F Guerrieri, ... Nature medicine 23 (3), 327-336, 2017 | 315 | 2017 |
| Combined GS-4774 and tenofovir therapy can improve HBV-specific T-cell responses in patients with chronic hepatitis C Boni, HLA Janssen, M Rossi, SK Yoon, A Vecchi, V Barili, EM Yoshida, ... Gastroenterology 157 (1), 227-241. e7, 2019 | 128 | 2019 |
| Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches P Fisicaro, V Barili, M Rossi, I Montali, A Vecchi, G Acerbi, D Laccabue, ... Frontiers in Immunology 11, 849, 2020 | 100 | 2020 |
| Neurogenin 2 regulates progenitor cell-cycle progression and Purkinje cell dendritogenesis in cerebellar development M Florio, K Leto, L Muzio, A Tinterri, A Badaloni, L Croci, P Zordan, ... Development 139 (13), 2308-2320, 2012 | 90 | 2012 |
| Natural killer cell phenotype modulation and natural killer/T‐cell interplay in nucleos (t) ide analogue‐treated hepatitis e antigen‐negative patients with chronic hepatitis B C Boni, P Lampertico, L Talamona, T Giuberti, F Invernizzi, V Barili, ... Hepatology 62 (6), 1697-1709, 2015 | 88 | 2015 |
| Local insulin-like growth factor I expression is essential for Purkinje neuron survival at birth L Croci, V Barili, D Chia, L Massimino, R van Vugt, G Masserdotti, ... Cell Death & Differentiation 18 (1), 48-59, 2011 | 68 | 2011 |
| Local insulin-like growth factor I expression is essential for Purkinje neuron survival at birth L Croci, V Barili, D Chia, L Massimino, R van Vugt, G Masserdotti, ... Cell Death & Differentiation 18 (1), 48-59, 2011 | 68 | 2011 |
| Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection G Missale, M Pilli, A Zerbini, A Penna, L Ravanetti, V Barili, A Orlandini, ... Gut 61 (7), 1076-1084, 2012 | 62 | 2012 |
| HBV immune-therapy: from molecular mechanisms to clinical applications C Boni, V Barili, G Acerbi, M Rossi, A Vecchi, D Laccabue, A Penna, ... International journal of molecular sciences 20 (11), 2754, 2019 | 59 | 2019 |
| MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93 L Montanini, L Lasagna, V Barili, SP Jonstrup, A Murgia, L Pazzaglia, ... Cellular oncology 35, 29-41, 2012 | 56 | 2012 |
| Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection V Barili, P Fisicaro, B Montanini, G Acerbi, A Filippi, G Forleo, C Romualdi, ... Nature communications 11 (1), 604, 2020 | 48 | 2020 |
| Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming P Fisicaro, C Boni, V Barili, D Laccabue, C Ferrari Current opinion in virology 30, 1-8, 2018 | 47 | 2018 |
| Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments E Cariani, M Pilli, V Barili, E Porro, E Biasini, A Olivani, R Dalla Valle, ... Oncoimmunology 5 (8), e1154249, 2016 | 46 | 2016 |
| ZFP423 coordinates Notch and bone morphogenetic protein signaling, selectively up-regulating Hes5 gene expression G Masserdotti, A Badaloni, YS Green, L Croci, V Barili, G Bergamini, ... Journal of biological chemistry 285 (40), 30814-30824, 2010 | 45 | 2010 |
| The good and the bad of natural killer cells in virus control: perspective for anti-HBV therapy P Fisicaro, M Rossi, A Vecchi, G Acerbi, V Barili, D Laccabue, I Montali, ... International journal of molecular sciences 20 (20), 5080, 2019 | 42 | 2019 |
| Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B G Acerbi, I Montali, GD Ferrigno, V Barili, S Schivazappa, A Alfieri, ... Journal of Hepatology 74 (4), 783-793, 2021 | 41 | 2021 |
| Zfp423/ZNF423 regulates cell cycle progression, the mode of cell division and the DNA-damage response in Purkinje neuron progenitors F Casoni, L Croci, C Bosone, R D'Ambrosio, A Badaloni, D Gaudesi, ... Development 144 (20), 3686-3697, 2017 | 33 | 2017 |
| Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer A Cavazzoni, G Digiacomo, R Alfieri, S La Monica, C Fumarola, M Galetti, ... Cancers 12 (3), 666, 2020 | 31 | 2020 |
| Intratumor regulatory noncytotoxic NK cells in patients with hepatocellular carcinoma A Zecca, V Barili, D Rizzo, A Olivani, E Biasini, D Laccabue, R Dalla Valle, ... Cells 10 (3), 614, 2021 | 24 | 2021 |
| Gene signatures associated with mouse postnatal hindbrain neural stem cells and medulloblastoma cancer stem cells identify novel molecular mediators and predict human … D Corno, M Pala, M Cominelli, B Cipelletti, K Leto, L Croci, V Barili, ... Cancer Discovery 2 (6), 554-568, 2012 | 24 | 2012 |
